GLP-1 signaling may improve mitochondrial biogenesis via PGC-1a/nuclear respiratory factor-1/mitochondrial transcription factor A signaling regulated by adiponectin/ adenosine 5-monophosphate (AMP)-activated protein kinase (AMPK) 49 and elevates the expression of NAD-dependent protein deacetylase sirtuin 1 (SIRT1), which increases the expression of Parkin, leading to mitophagy activation
The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects
So if you are interested, make sure to contact and reach out to our clinic, Sei Tu Bella
Key points for patients: GLP-1 therapies help clear skin and reduce painful, swollen joints Obesity makes PsA harder to treat, so weight loss from GLP-1 meds helps In studies, patients on GLP-1s had fewer flares, less pain, and felt better overall
Retatrutide clinical trial results The phase 2 trial, published in the New England Journal of Medicine, tested retatrutide at doses ranging from 1 mg to 12 mg weekly in adults with obesity
It was also worth noting that bucillamine could not reduce lead toxicity in red pulp macrophages, suggesting that thiol therapy is not effective for RBC recycling cells (Fig